Clinical Trials Browser

Phase 1/2 × Nelfinavir × Plasma cell × Clear all

NCT01555281 2022-07-07

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma